Iron homeostasis and disorders in dogs and cats: A review

Journal of the American Animal Hospital Association

Volumn 47, Issue 3, 2011, Pages 151-160

  McCown, Jennifer L ^a   Specht, Andrew J ^b  

^a PETS Referral Center   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ANIMAL; ANIMAL DISEASE; CAT; CAT DISEASE; DOG; DOG DISEASE; HOMEOSTASIS; IRON DEFICIENCY ANEMIA; IRON METABOLISM DISORDER; IRON OVERLOAD; METABOLISM; PHYSIOLOGY; REVIEW;

ANEMIA, IRON-DEFICIENCY; ANIMALS; CAT DISEASES; CATS; DOG DISEASES; DOGS; HOMEOSTASIS; IRON; IRON METABOLISM DISORDERS; IRON OVERLOAD;

CANIS FAMILIARIS;

EID: 79958193107     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/JAAHA-MS-5553     Document Type: Review

References (61)

1. Edison ES, Bajel A, Chandy M. Iron homeostasis: new players, newer insights. Eur J Haematol 2008;81(6):411-24.
2. Lieu PT, Heiskala M, Peterson PA, et al. The roles of iron in health and disease. Mol Aspects Med 2001;22(1-2):1-87.
3. Andrews GA, Smith JE. Iron metabolism. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's veterinary hematology. 5th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2000:129-34.
4. Harvey JW. The erythrocyte: physiology, metabolism and biochemical disorders. In: Kaneko JJ, Harvey JW, Bruss ML, eds. Clinical biochemistry of domestic animals. 5th ed. New York: Academic Press; 1997:157.
5. Smith JE. Iron metabolism and its disorders. Physiology, metabolism and biochemical disorders. In: Kaneko JJ, Harvey JW, Bruss ML, eds. Clinical biochemistry of domestic animals. 5th ed. New York: Academic Press; 1997:223.
6. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999; 341(26):1986-95.
7. Andrews NC. Forging a field: the golden age of iron biology. Blood 2008;112(2):219-30.
8. Subcommittee on Dog and Cat Nutrition, Committee on Animal Nutrition, National Research Council. Nutrient requirements of dogs and cats. Washington, DC: The National Academies Press; 2006:168-71.
9. Raffin SB, Woo CH, Roost KT, et al. Intestinal absorption of hemoglobin iron-heme cleavage by mucosal heme oxygenase. J Clin Invest 1974;54(6):1344-52.
10. Conrad ME, Umbreit JN, Moore EG. Iron absorption and transport. Am J Med Sci 1999;318(4):213-29.
11. Donovan A, Roy CN, Andrews NC. The ins and outs of iron homeostasis. Physiology (Bethesda) 2006;21:115-23.
12. Geiger U. Regenerative anemias caused by blood loss or hemolysis. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine. 6th ed. St. Louis (MO): Elsevier; 2005: 1886-907.
13. Davies M, Parry JE, Sutcliffe RG. Examination of different preparations of human placental plasma membrane for the binding of insulin, transferrin and immunoglobulins. J Reprod Fertil 1981; 63(2):315-24.
14. Enns CA, Suomalainen HA, Gebhardt JE, et al. Human transferrin receptor: expression of the receptor is assigned to chromosome 3. Proc Natl Acad Sci USA 1982;79(10):3241-5.
15. Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr 2006;26:323-42.
16. Fry MM, Liggett JL, Baek SJ. Molecular cloning and expression of canine hepcidin. Vet Clin Pathol 2004;33(4):223-7.
17. Kulaksiz H, Theilig F, Bachmann S, et al. The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol 2005;184(2):361-70.
18. Dallalio G, Law E, Means RT Jr. Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Blood 2006;107(7):2702-4.
19. Mena NP, Esparza A, Tapia V, et al. Hepcidin inhibits apical iron uptake in intestinal cells. Am J Physiol Gastrointest Liver Physiol 2008;294(1):G192-8.
20. Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 2001;98 (15):8780-5.
21. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 2002;99(7):4596-601.
22. Rivera S, Nemeth E, Gabayan V, et al. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 2005;106(6):2196-9.
23. Ristic JM, Stidworthy MF. Two cases of severe iron-deficiency anaemia due to inflammatory bowel disease in the dog. J Small Anim Pract 2002;43(2):80-3.
24. Rust MK, Dryden MW. The biology, ecology, and management of the cat flea. Annu Rev Entomol 1997;42:451-73.
25. Cook JD. Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol 2005;18(2):319-32.
26. Moore DF Jr, Sears DA. Pica, iron deficiency, and the medical history. Am J Med 1994;97(4):390-3.
27. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352(10):1011-23.
28. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113(9):1271-6.
29. Tilg H, Ulmer H, Kaser A, et al. Role of IL-10 for induction of anemia during inflammation. J Immunol 2002;169(4): 2204-9.
30. Park CH, Valore EV, Waring AJ, et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276(11): 7806-10.
31. Means RT Jr. Recent developments in the anemia of chronic disease. Curr Hematol Rep 2003;2(2):116-21.
32. Wang CQ, Udupa KB, Lipschitz DA. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development. J Cell Physiol 1995;162(1): 134-8.
33. Taniguchi S, Dai CH, Price JO, et al. Interferon gamma downregulates stem cell factor and erythropoietin receptors but not insulin-like growth factor-I receptors in human erythroid colonyforming cells. Blood 1997;90(6):2244-52.
34. Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res 1998;18(8):555-9.
35. Sprague WS, Hackett TB, Johnson JS, et al. Hemochromatosis secondary to repeated blood transfusions in a dog. Vet Pathol 2003; 40(3):334-7.
36. Albretsen J. The toxicity of iron, an essential element. Vet Med 2006; 101:82-90.
37. Plumb DC. Ferrous sulfate. In: Plumb DC, ed. Veterinary drug handbook. 6th ed. Ames (IA): Blackwell Publishing; 2008: 382-4.
38. Lisboa PE. Experimental hepatic cirrhosis in dogs caused by chronic massive iron overload. Gut 1971;12(5):363-8.
39. Giger U, Noble NA. Determination of erythrocyte pyruvate kinase deficiency in Basenjis with chronic hemolytic anemia. J Am Vet Med Assoc 1991;198(10):1755-61.
40. Dean BS, Krenzelok EP. In vivo effectiveness of oral complexation agents in the management of iron poisoning. J Toxicol Clin Toxicol 1987;25(3):221-30.
41. Feldman BF. Nonregenerative anemia. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine. 6th ed. St. Louis (MO): Elsevier; 2005:1908-17.
42. Harvey JW, Levin DE, Chen CL. Potential effects of glucocorticoids on serum iron concentration in dogs. Vet Clin Pathol 1987;16(2): 46-50.
43. Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem 2003;49(10):1573-8.
44. Meyer DJ, Harvey JW. Evaluation of erythrocyte disorders. In: Meyer DJ, Harvey JW, eds. Veterinary laboratory medicine interpretation and diagnosis. 2nd ed. Philadelphia (PA): WB Saunders; 2002:43-82.
45. Steinberg JD, Olver CS. Hematologic and biochemical abnormalities indicating iron deficiency are associated with decreased reticulocyte hemoglobin content (CHr) and reticulocyte volume (rMCV) in dogs. Vet Clin Pathol 2005;34(1):23-7.
46. Harvey JW. Microcytic anemias. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's veterinary hematology. 5th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2000:200-4.
47. Weiser G, O'Grady M. Erythrocyte volume distribution analysis and hematologic changes in dogs with iron deficiency anemia. Vet Pathol 1983;20(2):230-41.
48. Weeks BR, Smith JE, Stadler CK. Effect of dietary iron content on hematologic and other measures of iron adequacy in dogs. J Am Vet Med Assoc 1990;196(5):749-53.
49. Fry MM, Kirk CA. Reticulocyte indices in a canine model of nutritional iron deficiency. Vet Clin Pathol 2006;35(2):172-81.
50. Bhandari S, Norfolk D, Brownjohn A, et al. Evaluation of RBC ferritin and reticulocyte measurements in monitoring response to intravenous iron therapy. Am J Kidney Dis 1997;30(6):814-21.
51. Brugnara C, Zurakowski D, DiCanzio J, et al. Reticulocyte hemoglobin content to diagnose iron deficiency in children. JAMA 1999; 281(23):2225-30.
52. Brugnara C. Use of reticulocyte cellular indices in the diagnosis and treatment of hematological disorders. Int J Clin Lab Res 1998;28(1): 1-11.
53. Mast AE, Blinder MA, Lu Q, et al. Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood 2002; 99(4):1489-91.
54. Mittman N, Sreedhara R, Mushnick R, et al. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. Am J Kidney Dis 1997;30(6):912-22.
55. Schaefer RM, Schaefer L. Hypochromic red blood cells and reticulocytes. Kidney Int Suppl 1999;69:S44-8.
56. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002; 48(7):1066-76.
57. Ullrich C, Wu A, Armsby C, et al. Screening healthy infants for iron deficiency using reticulocyte hemoglobin content. JAMA 2005;294 (8):924-30.
58. Adams HR. Antianemic drugs. In: Booth NH, McDonald LE, eds. Veterinary pharmacology and therapeutics. Ames (IA): Iowa State University Press; 1988:469-81.
59. Harvey JW, French TW, Meyer JD. Chronic iron deficiency in dogs. J Am Aanim Hosp Aassoc 1982;18:946-60.
60. Mahaffey EA. Disorders of iron metabolism. In: Kirk RW, ed. Current veterinary therapy IX small animal practice. Philadelphia (PA): WB Saunders; 1986:521-4.
61. Plumb DC. Iron dextran. In: Plumb DC, ed. Veterinary drug handbook. 6th ed. Ames (IA): Blackwell Publishing; 2008: 493-4.